Wird geladen...
The fate of chemoresistance in triple negative breast cancer (TNBC)
BACKGROUND: Treatment options for women presenting with triple negative breast cancer (TNBC) are limited due to the lack of a therapeutic target and as a result, are managed with standard chemotherapy such as paclitaxel (Taxol®). Following chemotherapy, the ideal tumour response is apoptotic cell de...
Gespeichert in:
| Veröffentlicht in: | BBA Clin |
|---|---|
| Hauptverfasser: | , , , , , , , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Elsevier
2015
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4661576/ https://ncbi.nlm.nih.gov/pubmed/26676166 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbacli.2015.03.003 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|